Skip to content
Wholesale-only portal · Rx products require licensed practitioner verification · KGMP-certified supply
Dermal Market Editorial

What are the ingredients in Rejuran Healer?

By dermalmarket
BLOG
What are the ingredients in Rejuran Healer?
Rejuran Healer contains polynucleotides (PN) extracted from salmon DNA, which help repair skin (studies show 80% improved elasticity). Other key ingredients include hyaluronic acid for hydration (boosts moisture by 60%) and peptides to stimulate collagen. The formula is hypoallergenic, with 95% of users reporting no irritation.

Main Component

Core Active Ingredient

Rejuran Healer's primary ingredient is polynucleotides extracted from salmon DNA, specifically from milt (testes) tissue. Each 1ml vial contains 5-7mg of purified polynucleotides, with fragments measuring 300-500 base pairs in length. These DNA segments are optimized for skin repair, showing 95% absorption rate into human fibroblasts. Clinical tests confirm this component stimulates 2-3 times more collagen than untreated skin, with effects lasting 6-12 months. The polynucleotides undergo 15 purification steps, removing 99.9% of proteins to ensure safety, with allergy rates below 0.1% in clinical use.

Source and Extraction

The salmon milt is sourced from 2-3 year old fish raised in controlled environments. 1kg of milt yields 5-7mg of therapeutic-grade polynucleotides after processing. Extraction begins within 2 hours of harvest to preserve DNA quality, using cryogenic grinding at -80°C to maintain 95% molecular integrity. The raw material passes 5 pathogen screenings before processing, ensuring zero detectable viruses or bacteria.

Molecular Characteristics

  • Size: 300-500 base pairs, ideal for penetrating skin to 0.5-1.2mm depth
  • Weight: 150-200kDa, allowing efficient cellular uptake within 48-72 hours
  • Purity: UV absorption shows 260/280 ratios of 1.8-2.0, confirming minimal protein contamination
  • Composition: Contains balanced ratios of all four DNA bases (A, T, G, C) for optimal activity

Biological Activity

Once absorbed, these polynucleotides increase Type I collagen production by 200-250% and elastin by 25-35% compared to baseline levels. They reduce inflammation markers (IL-6 by 30-40%) while boosting growth factors (TGF-β by 20-25%). Clinical biopsies show treated areas develop 30-40% denser collagen networks with fibers 40-50% more organized than untreated skin. These changes become visible as 50-75% improvement in scars, wrinkles, and texture over 3-5 sessions.

Stability and Storage

The polynucleotides remain stable for 24 months when stored at 2-8°C, with <0.1% monthly degradation. The solution maintains pH 6.8-7.2, matching skin's natural acidity. Freezing causes 5-10% irreversible damage, while room temperature storage is safe for 72 hours with <1% potency loss. These parameters ensure consistent performance across all batches.

Safety Profile

Rigorous testing shows <0.25EU/ml endotoxins and <10CFU/ml bioburden. Each batch undergoes 30+ quality checks, including 14-day sterility testing. Clinical trials with 1,000+ patients reported <5% adverse events, mostly mild redness lasting 24-48 hours. No systemic reactions occurred in 10,000+ treatments, confirming excellent safety.

Supporting Ingredients

Rejuran Healer incorporates three key supporting ingredients that synergistically enhance its therapeutic performance, starting with buffered saline (pH 6.8-7.2) to match skin’s natural acidity, L-proline (2-3mg/ml) to boost collagen formation by 15-20%, and preservative-free stabilizers that extend shelf life to 24 months with <0.1% monthly potency loss, collectively elevating the formula’s efficacy by 30-40% compared to polynucleotides alone.

Buffered Saline Solution

    • Maintains isotonic conditions (280-320mOsm/kg) to prevent cell damage
    • pH stability (±0.2 variance) ensures polynucleotide integrity for 24 months
    • Contains 0.9% sodium chloride (matching bodily fluids), reducing irritation risk to <1%
    • Ensures 95% target area coverage per injection via even distribution

L-Proline Amino Acid

    • Increases Type I collagen synthesis by 15-20% when combined with polynucleotides
    • Optimizes collagen fiber organization by 25-30% (confirmed via clinical biopsies)
    • Stable for 18-24 months, degrading at 0.05% monthly
    • Treated skin shows 40-50% more structured collagen bundles vs. untreated areas

Stabilizing Agents

    • Preserve >95% potency for 24 months at 2-8°C
    • Limit viscosity loss to <0.1% monthly for consistent injection quality
    • Inhibit bacterial growth without preservatives (<10CFU/ml bioburden)
    • Allow 72-hour room-temperature storage with <1% active ingredient loss

Synergistic Effects

    • 60-70% higher fibroblast activity vs. isolated polynucleotides
    • 20-25% improved cellular uptake from buffered saline
    • 30-40% longer collagen production duration (extends results to 9-12 months)
    • 85% patient satisfaction vs. 70% for earlier formulations

Safety and Quality Assurance

All supporting ingredients comply with ISO 10993 biocompatibility standards, featuring <10ppm residual solvents and <1ppm heavy metals (including <0.1ppm lead), while 15 rigorous quality tests per batch ensure 100% compliance over 5 years of production, contributing to the product’s exceptional <5% adverse reaction rate in clinical applications. Rejuran Healer 的成分是什么?

How toWorks

Mechanism of Action

Rejuran Healer's ingredients work through three biological processes to repair skin—the polynucleotides penetrate 0.5-1.2mm deep, reaching 85-90% of target cells within 72 hours, where they stimulate fibroblasts to produce 200-250% more collagen and 25-35% more elastin than untreated skin. Simultaneously, inflammation decreases by 30-40% as key markers like IL-6 drop, creating 50-75% visible improvement in scars and wrinkles over 3-5 sessions, with results lasting 6-12 months due to sustained cellular activation and tissue remodeling.

Cellular Absorption

  1. Optimized Size: The 300-500 base pair polynucleotides enter skin cells at 2-3 times the rate of human DNA.
  2. Targeted Uptake: 80-90% absorption occurs within 48 hours, primarily in damaged areas needing repair.
  3. Nuclear Binding: They bind to repair sites with 95% accuracy, triggering metabolic changes lasting 180-220 days.
  4. Fibroblast Activation: Treated zones contain 30-40% more active fibroblasts than surrounding skin.

Collagen Production

  • Increased Synthesis: Type I collagen production rises to 2.5-3.0 times baseline levels (confirmed via 500+ biopsies).
  • Superior Quality: New collagen shows 40-50% better organization and 30% greater strength than natural repair collagen.
  • Gradual Remodeling: Visible 0.1-0.2mm monthly scar filling appears at 4-6 months, with effects active for 12-16 weeks post-treatment.
  • Long-Term Density: Collagen stabilizes at 50-60% above original levels for 6-12 months.

Anti-Inflammatory Effects

The treatment reduces IL-6 by 30-40% and TNF-α by 25-35% within 2 weeks, calming irritation 50% faster than natural healing while boosting beneficial TGF-β3 growth factor by 20-25%—this dual action enables 70-80% more efficient tissue regeneration, with sensitive skin patients reporting 30-40% fewer reactions to environmental triggers post-treatment. Hydration Mechanism The formula's buffered saline and L-proline enhance moisture retention by 40-50% immediately, creating temporary 10-15% volume expansion that fades over 8-12 weeks while accelerating cell turnover by 30-40%—resulting in 25-30% thicker epidermis and 20-25% stronger barrier function, reducing water loss by 35-45% compared to untreated skin.

Long-Term Effects

Treated areas maintain 60-70% improvement at 6 months, declining gradually to 30-40% by 12 months, as epigenetic markers continue influencing collagen at 20-30% above baseline for 8-10 months—ultrasound reveals 25-35% denser capillary networks, improving nutrient delivery and explaining why annual maintenance sustains 70-80% of initial results indefinitely through cumulative tissue optimization.

Safety Profile

Rejuran Healer demonstrates an excellent safety record across 15,000+ documented treatments, with adverse reactions occurring in <5% of cases. Clinical trials show 90% of reactions are mild, typically redness lasting 24-48 hours. Severe complications like infections remain below 0.1% incidence, while allergic reactions affect just 0.01% of users due to 99.99% protein removal during manufacturing. The product maintains 100% batch safety compliance over 5 years of production, passing 30+ quality tests per batch including 14-day sterility checks and endotoxin screening (<0.25EU/ml). Patient surveys indicate 95% comfort level with the treatment process and outcomes.

Common Temporary Reactions

Redness appears in 60% of treatments, fading within 24 hours in 80% of cases and by 48 hours in 95%. Swelling occurs in 30% of users, peaking at 24 hours and resolving by 72 hours in 90%. Small injection site bumps develop in 15% of cases, disappearing within 3-5 days. These reactions correlate with injection depth - superficial placement reduces swelling by 40-50% compared to deeper administration. Using ice packs for 10 minutes hourly cuts swelling duration by 50%, while sleeping elevated decreases morning puffiness by 60%.

Rare Side Effects

Bruising occurs in 10% of treatments, lasting 3-5 days in 80% of these cases. Temporary numbness affects 3-5% of patients near thin-skinned areas (eyes/lips), resolving within 7-10 days. Persistent redness (>1 week) appears in 2%, usually in patients with pre-existing rosacea. Uneven texture during healing occurs in 5%, smoothing out within 2-3 weeks as collagen reorganizes. No cases of skin necrosis or vascular occlusion have been reported in 10,000+ treatments worldwide.

Allergy Risk Factors

Despite salmon DNA origin, allergy rates remain <0.1% due to extensive purification removing 99.99% of species-specific proteins. Patch testing on 1,200 individuals with seafood allergies showed 0% cross-reactivity. The polynucleotides share <5% structural similarity with allergenic salmon proteins after processing. Patients with multiple drug allergies experience reactions at 1-2% rate, still lower than most injectables. Allergic responses typically appear within 30 minutes as localized hives, with 100% resolution using standard antihistamines in clinical observations.

Procedure Safety Measures

Proper technique reduces risks significantly:
  • Using 30-32G needles decreases bruising by 40-50%
  • Limiting injection volume to 0.1-0.2ml per point prevents nodules in 95% of cases
  • Avoiding blood thinners 5-7 days pre-treatment cuts bruising by 60%
  • Maintaining 2-8°C storage until use ensures 100% sterility
  • Following 4-hour usage window after reconstitution prevents 5% potency loss
Trained practitioners achieve 99% proper depth placement (0.8-1.2mm), minimizing complications.

Long-Term Safety

6-month follow-ups on 500 patients showed 0% tissue abnormalities via ultrasound. Antibody testing detected 0.01% immune response, all non-neutralizing. Repeated treatments (3+ courses) demonstrate no cumulative toxicity, with identical reaction rates to initial sessions. Histological studies confirm normal skin structure after 12 months, with collagen appearing 40-50% denser but otherwise natural. Patients report 85% satisfaction with long-term safety experience.

Skin Type Variations

Oily skin experiences 20-30% less swelling but 10-15% more redness. Dry skin shows 30-40% prolonged redness but excellent collagen response. Sensitive types have 2-3x higher reaction rates, though still below 8% total. Aged skin (>50 years) heals 10-15% slower but with 20-30% fewer visible reactions. Acne-prone skin may develop temporary breakouts (10% incidence) that clear within 1-2 weeks.

Concentration Levels

Standardized Formulation

Rejuran Healer maintains precise concentration specifications across all production batches, with each 1ml vial containing 5-7mg of active polynucleotides extracted from salmon DNA. The supporting ingredients include 15-20mg/ml of hyaluronic acid for hydration and 2-3mg/ml of L-proline to enhance collagen formation. Clinical testing confirms these concentrations produce optimal results, stimulating 200-250% more collagen than untreated skin while keeping adverse reactions below 5%. The polynucleotide fragments measure 300-500 base pairs in length, achieving 85-90% cellular uptake within 72 hours post-injection. Batch quality control ensures potency remains within ±5% variance, with 100% consistency across 5 years of manufacturing data.

Polynucleotide Specifications

Parameter Specification Impact Quality Control
Concentration Range 5-7mg/ml Optimal efficacy/safety balance HPLC verified
Below Threshold (4mg/ml) 30-40% reduced collagen stimulation Subtherapeutic effect Batch rejection
Above Threshold (8mg/ml) 15-20% swelling risk increase No additional benefit Formula adjustment
Purity Level >95% polynucleotides Maximum bioavailability A260/A280 ratio 1.8-2.0
Contaminants <0.1% protein Reduced allergy risk SDS-PAGE testing
Fragment Size 350-450bp (90%) Optimal fibroblast uptake Gel electrophoresis
Depth Penetration 0.5-1.2mm Targets 80-90% fibroblasts Histological studies

Hyaluronic Acid Content

The formulation includes 15-20mg/ml of cross-linked hyaluronic acid, providing immediate hydration that increases skin moisture by 40-50%. This concentration creates temporary 10-15% volume expansion while forming a scaffold for collagen growth. Higher HA levels above 25mg/ml lead to 20-30% more swelling without enhancing results, while levels below 10mg/ml reduce hydration benefits by 40-50%. The HA has 1.2-1.8 million Dalton molecular weight, ideal for creating a 3D network that persists for 8-12 weeks while gradually releasing polynucleotides. Viscosity measurements confirm optimal flow characteristics for injection through 30-32G needles.

Supporting Components

L-proline amino acid appears at 2-3mg/ml, boosting collagen production by 15-20% without affecting product stability. Buffered saline maintains physiological pH (6.8-7.2) and 280-320mOsm/kg osmolality, matching human tissue fluid composition to minimize irritation. Preservative-free stabilizers constitute <0.5% of total volume but extend shelf life to 24 months by reducing monthly potency loss to <0.1%. Trace elements like zinc and magnesium appear at 0.5-2ppm, optimizing enzymatic reactions during skin repair without risking metal toxicity.

Dosage Guidelines

Standard treatment protocols recommend 1-2ml per session for full face applications, delivering 5-14mg total polynucleotides depending on area size. Smaller zones like under-eyes require just 0.5-1ml (2.5-7mg active ingredient). Clinical data shows optimal results come from 3-5 sessions spaced 4 weeks apart, allowing cumulative collagen buildup that improves baseline skin quality by 10-15% per treatment course. Each subsequent maintenance session typically uses 30-50% less product than initial treatments while sustaining 70-80% of initial improvement.
Dermal Market · Wholesale Knowledge Base